Can the Analysis of ERCC1 Expression Contribute to Individualized Therapy in Nasopharyngeal Carcinoma?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Can the Analysis of ERCC1 Expression Contribute to Individualized Therapy in Nasopharyngeal Carcinoma?

Published:2011-04 Issue:5 Volume:79 Page:1414-1420
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Chan Siu Hong,Cheung Florence M.F.,Ng Wai Tong,Choi Cheuk Wai,Cheung Kin Nam,Yiu Kwan Ho,Lee Anne W.M.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference29 articles.

1. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099;Al-Sarraf;J Clin Oncol,1998

2. Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: Positive effect on overall and progression-free survival;Lin;J Clin Oncol,2003

3. Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group;Lee;J Clin Oncol,2005

4. Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety;Wee;J Clin Oncol,2005

5. Treatment results for nasopharyngeal carcinoma in the modern era: The Hong Kong experience;Lee;Int J Radiat Oncol Biol Phys,2005

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Could excision repair cross‐complementing group‐1 mRNA expression from peripheral blood lymphocytes predict locoregional failure with cisplatin chemoradiation for locally advanced laryngeal cancer?;Asia-Pacific Journal of Clinical Oncology;2020-04

2. The prognostic value of excision repair cross-complementing Group 1 expression in nasopharyngeal cancer patients;Journal of Research in Medical Sciences;2020

3. High/positive expression of ERCC1 predicts poor treatment response and survival prognosis in nasopharyngeal carcinoma;Medicine;2019-05

4. Is excision repair cross-complementation Group1 expression a biological marker in nasopharynx carcinoma?;Journal of Cancer Research and Therapeutics;2019

5. Predictive value of excision repair cross-complementation group 1 protein in locoregionally advanced nasopharyngeal carcinomas receiving cisplatin-based concurrent chemoradiotherapy;Journal of Cancer Research and Therapeutics;2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3